Treatment-resistant cases — depression, anxiety, OCD, bipolar, or other conditions that haven’t responded adequately to standard treatment — often benefit from specialist consultation or care. Many patients spend years cycling through inadequate treatment when specialty input could direct effective intervention.
Knowing when treatment resistance warrants specialist care, and what that care typically involves, helps patients access better outcomes.
What Defines “Treatment-Resistant”
Treatment-Resistant Depression (TRD)
Generally defined as failure to respond adequately to 2+ antidepressant trials of adequate dose and duration. Some definitions require 3+ trials.
Treatment-Resistant OCD
Failure of 2+ adequate SSRI trials at OCD doses (often higher than depression doses) for adequate duration (12+ weeks each).
Treatment-Resistant Anxiety
Failure of 2+ adequate medication trials for the specific anxiety condition.
Treatment-Resistant Bipolar
Failure to achieve adequate mood stabilization despite multiple mood stabilizer trials.
“Adequate trial” definition
Important — many cases labeled treatment-resistant actually haven’t had adequate trials. Adequate means appropriate dose and adequate duration (typically 6-12 weeks at therapeutic dose for most conditions).
When to Consider Specialty Care
Multiple failed standard treatments
After 2-3 inadequate response trials in standard care, specialty consultation often warranted.
Persistent significant impairment
Continued substantial impact on work, relationships, function despite treatment.
Diagnostic complexity
Multiple coexisting conditions, atypical presentations, or unclear diagnosis.
Complex medication regimens
Multiple psychiatric medications without clear effectiveness.
Considering advanced treatments
Esketamine/ketamine, TMS, ECT, or other advanced treatments warrant specialist evaluation.
Persistent treatment-emergent issues
Continued significant side effects, manic switches, or other complications.
Suicide risk despite treatment
Persistent suicidality despite engagement with treatment.
What Specialists Typically Add
Comprehensive reassessment
Specialists typically conduct thorough re-evaluation — questioning diagnostic assumptions, screening for missed conditions, evaluating current treatment thoroughly.
Missed diagnoses
Often identify previously missed conditions:
- Bipolar features in apparent unipolar depression
- ADHD complicating depression or anxiety
- Trauma contributions
- Personality features
- Medical contributors (thyroid, sleep apnea, B12)
- Substance contributors
Evidence-based augmentation
Knowledge of and access to evidence-based augmentation strategies that primary providers may not use:
- Lithium augmentation
- Thyroid (T3) augmentation
- Atypical antipsychotic augmentation
- Combined antidepressants
- Specific OCD augmentation strategies
Advanced treatment options
Access to or coordination with:
- Esketamine (Spravato) and ketamine
- TMS (Transcranial Magnetic Stimulation)
- ECT (Electroconvulsive Therapy)
- Specialty therapy referrals (ERP for OCD, prolonged exposure for PTSD)
Treatment optimization
Systematic optimization including:
- Dose adjustment to therapeutic ranges
- Adequate trial duration
- Measurement-based response tracking
- Coordination of medication and therapy
- Addressing lifestyle and medical contributors
Coordination of complex care
Coordination with therapists, primary care, and other specialists.
Models of Specialty Care
Specialist consultation
One-time or limited consultation providing recommendations back to primary psychiatrist — see related article on second opinions.
Specialist as primary psychiatrist
For complex ongoing cases, specialist may become primary psychiatrist for the duration of treatment-resistant phase.
Tertiary care programs
Some academic centers have specific treatment-resistant programs with multidisciplinary teams.
Coordinated specialty care
Specialist provides specific aspects (e.g., medication management) while primary psychiatrist or therapist provides others.
Source: Clinical research on treatment-resistant psychiatric care.
Stalled in standard care
Patients with complex situations often spend years in standard care without progress — when specialty input could direct effective intervention.
Comprehensive specialty evaluation
Dr. Farkas provides treatment-resistant evaluation and management — diagnostic reassessment, evidence-based optimization, advanced treatment access.
Real progress
Many treatment-resistant patients achieve meaningful progress with specialty care — sometimes substantial improvement that years of standard care didn’t produce.
Common Questions About Treatment-Resistant Specialty Care
How do I know if I’m really treatment-resistant?
Specialty evaluation can confirm. Often what looks like resistance is actually inadequate trials — proper dose, duration, or augmentation not yet attempted.
Will I have to start over with all new providers?
Not necessarily. Specialty consultations can complement existing care. For complex ongoing situations, specialty care may become primary.
What treatments might be different in specialty care?
Many — different augmentation strategies, different medication combinations, advanced treatments (TMS, esketamine, ECT), specific therapy approaches. See our related articles on treatment-resistant depression and treatment-resistant anxiety.
Is this admitting failure?
No — it’s recognizing that complex cases often need specialty input. Some conditions and patients simply need more specialized attention.